
|Videos|June 6, 2023
Approved PSMA-PET Imaging Tracer Options for Prostate Cancer
The panel reviews the similarities and differences between the FDA-approved PSMA-PET tracer options for prostate cancer imaging.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
HHS requests testosterone therapy label updates, citing new safety data
2
Unmet needs and emerging solutions in MRI-guided prostate cancer care
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Pearls & Perspectives: The Power of Advocacy in Sexual Medicine, With Rachel Rubin, MD
5















